by Jeremy Martin | Oct 11, 2012
A US bill aimed to stop price overcharging during drug shortages has proceeded to the Senate Committee stage. New York Senator Charles Schumer introduced the “Protecting Patients and Hospitals From Price Gouging Act” to put halt to suppliers, pharmas, and any party...
by Jeremy Martin | Oct 4, 2012
Check out Pearl’s President and CEO featured in the Indiana University Center for the Business of Life Sciences video. For the past six years, the Kelley school has been hosting quarterly events across the state with life science leaders to consider, discuss, and...
by Jeremy Martin | Oct 3, 2012
A recent article by Xconomy explores the movement of biotech and the healthcare industry integrating their way into social media, Twitter specifically. Twitter is growing at a rapid pace and will enjoy approximately 250million users by the end of 2012. Gautam Kollu...
by Jeremy Martin | Sep 26, 2012
The European Medicines Agency delivered draft guidance documents focused on the quality of oral modified release products and transdermal delivery patches last week. The EMA expects feedback by March 2013. The guidelines for patches are directed toward developers and...
by Jeremy Martin | Sep 21, 2012
The IMDMC 2012 annual conference will be held on Wednesday October 17, 2012 at the Montage Meeting Facility in Indianapolis, Indiana. Come prepared for a full day of events. The conference features FDA’s Steve Silverman, Director, Office of Compliance, and CDRH. Pearl...